Exagen Inc. (XGN)

Exagen Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-23.69	-47.39	-26.85	-16.69	-30.28
Depreciation & Amortization	3.11	2.52	0.95	0.55	0.59
Share-Based Compensation	3.62	4.7	4.73	2.69	0.57
Other Operating Activities	2.5	8.02	0.91	-0.64	1.16
Operating Cash Flow	-14.46	-32.14	-20.27	-14.08	-9.71
Capital Expenditures	-0.8	-4.32	-2.37	-0.46	-0.1
Other Investing Activities	-	-	-0.05	-	-
Investing Cash Flow	-0.8	-4.32	-2.42	-0.46	-0.1
Share Issuance / Repurchase	0.31	0.45	65.25	0.17	50.44
Debt Issued / Paid	-10.94	-0.7	-0.53	-0.25	-0.14
Other Financing Activities	-	-0.24	-0.04	-0.02	18.43
Financing Cash Flow	-10.63	-0.49	64.68	-0.1	68.73
Net Cash Flow	-25.9	-36.95	41.99	-14.64	58.92
Free Cash Flow	-15.27	-36.46	-22.64	-14.54	-9.81
Free Cash Flow Margin	-29.05%	-80.03%	-46.87%	-34.64%	-24.30%
Free Cash Flow Per Share	-0.86	-2.13	-1.42	-1.15	-2.74

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).